Columbia Threadneedle, Ameriprise Financial’s global asset‑management arm, announced the launch of six new exchange‑traded funds, bringing its U.S. ETF lineup to 20 products. The new suite includes three equity ETFs—an international equity, a mid‑cap, and a small‑cap fund—each designed to provide research‑enhanced exposure that removes low‑conviction securities from traditional index baskets. The fixed‑income side adds a corporate bond ETF (CCRP), a core‑plus bond ETF (CRXP, launched 12/11/2025), and a CLO‑focused ETF (AAAC). These launches are part of Ameriprise’s broader strategy to grow its asset‑management segment, which recently achieved a 42% pretax operating margin in Q3 2025.
The equity ETFs build on Columbia Threadneedle’s research‑enhanced active strategy, which blends quantitative screens with fundamental analysis to identify high‑conviction stocks. By excluding low‑conviction securities, the funds aim to deliver alpha while maintaining lower volatility than traditional index funds. The international equity fund targets high‑growth markets outside the U.S., the mid‑cap fund focuses on companies with market capitalizations between $2 billion and $10 billion, and the small‑cap fund targets companies below $2 billion, offering investors diversified exposure across the equity spectrum.
On the fixed‑income side, the Columbia Corporate Bond ETF (CCRP) offers broad exposure to investment‑grade corporate debt, while the Columbia Core Plus Bond ETF (CRXP) focuses on high‑yield corporate bonds with a credit‑enhanced mandate. The Columbia AAA CLO ETF (AAAC) provides access to collateralized loan obligations backed by high‑quality loans, a niche that has attracted institutional demand. The launch of these three fixed‑income ETFs complements the equity offerings and positions Columbia Threadneedle to capture fee‑generating assets across both asset classes.
The 42% pretax operating margin for the asset‑management segment in Q3 2025 reflects strong fee growth and disciplined cost management. The margin expansion was driven by higher fee income from the new ETFs and existing products, offset by modest increases in operating expenses. The segment’s revenue grew 8% YoY to $1.2 billion, driven by a 12% increase in assets under management for the new ETFs and a 5% rise in fee‑based income from existing funds.
Management emphasized that the new ETF lineup strengthens Ameriprise’s integrated wealth‑management model by giving advisors a broader suite of actively managed solutions. “These new products reinforce our commitment to delivering differentiated, cost‑efficient active strategies that meet the evolving needs of our clients,” said a Columbia Threadneedle spokesperson. The launch is expected to deepen client relationships and generate additional fee income, supporting the firm’s long‑term growth strategy.
The expansion to 20 U.S. ETFs places Columbia Threadneedle among the largest active ETF providers in the market, positioning the firm to capture a larger share of the growing active ETF market, which is projected to grow at a compound annual growth rate of 12% over the next five years. The new offerings also provide a competitive edge against passive index funds by offering active management with lower expense ratios than many actively managed mutual funds.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.